The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease
2008 ◽
Vol 28
(17)
◽
pp. 4311-4316
◽
2001 ◽
Vol 8
(6)
◽
pp. 579-586
◽
Keyword(s):